MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3. - Wikidata - awgldk - TriplyDB

MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

http://www.wikidata.org/entity/Q33733031

about

Testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma.The tumor suppressor role of microRNA-338-3p in renal cell carcinoma.MiR-384 inhibits the proliferation of colorectal cancer by targeting AKT3

P2860

Q48191673-1F4D9F0B-5198-48D0-92F6-D0F330FBA2EA Q55618724-5C93CE53-943C-4904-A826-682B7C16F2F1 Q58768739-ACC3BD1A-2B2C-4577-AB43-D3C1C7225829

P2860

MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

http://www.wikidata.org/entity/Q33733031

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

@ast

MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

@en

type

label

MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

@ast

MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

@en

prefLabel

MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

@ast

MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

@en

P1433

Q33733031-87A2D87B-99C8-4437-B966-9C17595BA55E

P1476

Q33733031-A497FFEB-D898-4E9F-8245-F1AC55BF9A0B

P2093

Q33733031-0C560616-8386-41EA-AF47-D76583B99D26

Q33733031-18616BE0-5481-476C-AA92-9794BE7333A3

Q33733031-3E54D3F2-4C7F-4B2F-87F8-601F8EB142DE

Q33733031-713DAADC-1D67-4CF0-9449-23F250B59D42

Q33733031-9D22EDFB-FECF-4EF6-964A-A5167DCC8115

Q33733031-C7E04B2E-3EB2-4265-8DA8-2B74AC913CCF

Q33733031-F1E3EC9A-1A83-414A-A364-373C2E958943

P2860

Q33733031-0279A921-2310-4FF2-81DC-A4D0C941FB27

Q33733031-02E2E999-567F-4407-9A08-1850B8F33A9B

Q33733031-08DE5C1F-71D9-442B-9437-96EA874F28C3

Q33733031-0985A0EA-7C88-4110-AB66-41702D0B3B99

Q33733031-14AABBB9-22C9-4491-B5CD-0D262D8DA21F

Q33733031-1B03E802-579B-4DE4-8156-1DBDB34F8AE9

Q33733031-2A28F7CF-B776-49CA-82B7-94F08F02E5BF

Q33733031-360F042F-FAD5-4F14-88C2-8C07C944E4E4

Q33733031-394032EA-ECAD-403E-BE18-DE8817321A48

Q33733031-3CA5B95F-2CBE-4406-B9A5-6FEB77DCA463

P304

Q33733031-9A30D500-D2AC-413A-957A-9527AB19C75C

P31

Q33733031-004D66C0-3ADB-4209-AACA-14151E126004

P433

Q33733031-4E8F12F6-048B-41F5-8746-41CE915B44F9

P478

Q33733031-A882A44E-798F-466E-9B42-93ABF2D22F4C

P577

Q33733031-71926243-E4FB-4245-B4F4-1CD421486734

P698

Q33733031-5E2559F8-8459-47FD-B514-02CA4439BBBA

P932

Q33733031-686C7CEF-95E3-427B-9A58-07C31917FFB3

P1433

American Journal of Cancer Research

P1476

MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

@en

P2093

Dan Fei

http://www.w3.org/2001/XMLSchema#string

Feng Guo

http://www.w3.org/2001/XMLSchema#string

Guo-Qing Sui

http://www.w3.org/2001/XMLSchema#string

Hui Wang

http://www.w3.org/2001/XMLSchema#string

Qiang Luo

http://www.w3.org/2001/XMLSchema#string

Shuai Yin

http://www.w3.org/2001/XMLSchema#string

Xi Zhen

http://www.w3.org/2001/XMLSchema#string

P2860

Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4

Cancer statistics, 2013

MicroRNA signatures in human cancers

MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α

microRNA functions

MicroRNAs in cell proliferation, cell death, and tumorigenesis.

MicroRNAs in thyroid cancer.

Current Diagnosis and Management of Thyroid Nodules.

Activation of AKT kinases in cancer: implications for therapeutic targeting.

Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects.

P304

1177-1187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28560065

http://www.w3.org/2001/XMLSchema#string

P932

5446482

http://www.w3.org/2001/XMLSchema#string